Silver Book Fact

The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.

Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. May 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
May 2011
Authors
Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • An estimated 424,801 more visually impaired and blind individuals live in nursing homes than would be expected if they had normal vision.  
  • Even mild visual impairment more than doubles the risk of mortality over a 5-year period.  
  • Over a 1-year period, 54% of individuals with age-related macular degeneration (AMD) reported a fall and 30% reported more than one.  Of all reported falls, 63% resulted in an injury.  
  • Visual impairment (compared to no visual impairment) is associated with more than $1,000 in excess annual medical expenses per person.  
  • An estimated 79,268 Americans ages 50-54 have age-related macular degeneration (AMD). That grows to 231,373 at ages 75-79 and more than 1.3 million for ages 80+.